HK1068154A1 - Anaplastic lymphoma kinase assay, reagent and compositions thereof - Google Patents
Anaplastic lymphoma kinase assay, reagent and compositions thereofInfo
- Publication number
- HK1068154A1 HK1068154A1 HK05101314A HK05101314A HK1068154A1 HK 1068154 A1 HK1068154 A1 HK 1068154A1 HK 05101314 A HK05101314 A HK 05101314A HK 05101314 A HK05101314 A HK 05101314A HK 1068154 A1 HK1068154 A1 HK 1068154A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- reagent
- kinase assay
- anaplastic lymphoma
- lymphoma kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03005186A EP1454992B1 (en) | 2003-03-07 | 2003-03-07 | Anaplastic lymphoma kinase assay, reagents and compositions thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1068154A1 true HK1068154A1 (en) | 2005-04-22 |
Family
ID=32798804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05101314A HK1068154A1 (en) | 2003-03-07 | 2005-02-17 | Anaplastic lymphoma kinase assay, reagent and compositions thereof |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070031907A1 (xx) |
EP (1) | EP1454992B1 (xx) |
JP (1) | JP2006519800A (xx) |
CN (1) | CN100345978C (xx) |
AT (1) | ATE328112T1 (xx) |
CA (1) | CA2518094A1 (xx) |
CY (1) | CY1106115T1 (xx) |
DE (1) | DE60305634T2 (xx) |
DK (1) | DK1454992T3 (xx) |
ES (1) | ES2263862T3 (xx) |
HK (1) | HK1068154A1 (xx) |
IL (1) | IL170669A0 (xx) |
PT (1) | PT1454992E (xx) |
SI (1) | SI1454992T1 (xx) |
WO (1) | WO2004079326A2 (xx) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2561406T3 (es) | 2006-04-14 | 2016-02-26 | Cell Signaling Technology, Inc. | Defectos de genes y quinasa ALK mutante en tumores sólidos humanos |
US8168383B2 (en) | 2006-04-14 | 2012-05-01 | Cell Signaling Technology, Inc. | Gene defects and mutant ALK kinase in human solid tumors |
EP2107054A1 (en) | 2008-04-01 | 2009-10-07 | Università Degli Studi Di Milano - Bicocca | Antiproliferative compounds and therapeutic uses thereof |
EP2274288A2 (en) | 2008-04-24 | 2011-01-19 | Incyte Corporation | Macrocyclic compounds and their use as kinase inhibitors |
EP2161271A1 (en) | 2008-09-08 | 2010-03-10 | Università Degli Studi Di Milano - Bicocca | Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl |
WO2010085597A1 (en) | 2009-01-23 | 2010-07-29 | Incyte Corporation | Macrocyclic compounds and their use as kinase inhibitors |
US9126931B2 (en) * | 2009-06-10 | 2015-09-08 | Chugai Seiyaku Kabushiki Kaisha | Tetracyclic compound |
CN101955995B (zh) * | 2010-06-17 | 2013-06-26 | 江苏迈迪基因生物科技有限公司 | 淋巴瘤相关的融合基因的诊断试剂盒 |
US20120101108A1 (en) | 2010-08-06 | 2012-04-26 | Cell Signaling Technology, Inc. | Anaplastic Lymphoma Kinase In Kidney Cancer |
WO2012023597A1 (ja) | 2010-08-20 | 2012-02-23 | 中外製薬株式会社 | 4環性化合物を含む組成物 |
EP2847353B1 (en) | 2012-05-10 | 2022-01-19 | The General Hospital Corporation | Methods for determining a nucleotide sequence |
TR201815994T4 (tr) | 2012-09-25 | 2018-11-21 | Chugai Pharmaceutical Co Ltd | Ret inhibitörü. |
WO2014128235A1 (en) | 2013-02-22 | 2014-08-28 | F. Hoffmann-La Roche Ag | Methods of treating cancer and preventing drug resistance |
US10450597B2 (en) | 2014-01-27 | 2019-10-22 | The General Hospital Corporation | Methods of preparing nucleic acids for sequencing |
CA2946268A1 (en) | 2014-04-25 | 2015-10-29 | Chugai Seiyaku Kabushiki Kaisha | Crystal of tetracyclic compound |
KR102412321B1 (ko) | 2014-04-25 | 2022-06-22 | 추가이 세이야쿠 가부시키가이샤 | 4환성 화합물을 고용량 함유하는 제제 |
TWI718102B (zh) | 2014-08-08 | 2021-02-11 | 日商中外製藥股份有限公司 | 4環性化合物的非晶質體 |
RU2740261C2 (ru) | 2015-01-16 | 2021-01-12 | Чугаи Сейяку Кабусики Кайся | Комбинированное лекарственное средство |
CN109937254B (zh) | 2016-09-15 | 2023-05-30 | 阿谢尔德克斯有限责任公司 | 核酸样品制备方法 |
CA3037190A1 (en) | 2016-09-15 | 2018-03-22 | ArcherDX, Inc. | Methods of nucleic acid sample preparation for analysis of cell-free dna |
EP4198140A1 (en) | 2016-11-02 | 2023-06-21 | ArcherDX, LLC | Methods of nucleic acid sample preparation for immune repertoire sequencing |
WO2020050241A1 (ja) | 2018-09-04 | 2020-03-12 | 中外製薬株式会社 | 4環性化合物の製造方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05126833A (ja) * | 1991-10-31 | 1993-05-21 | Tosoh Corp | チロシンキナ−ゼ活性の免疫化学的測定法及びそのキツト |
AU4281393A (en) * | 1992-04-10 | 1993-11-18 | Dana-Farber Cancer Institute, Inc. | Activation-state-specific phosphoprotein immunodetection |
ES2136103T3 (es) * | 1992-06-22 | 1999-11-16 | Kyowa Hakko Kogyo Kk | Procedimiento para la preparacion de derivados de estaurosporina. |
GB9314271D0 (en) * | 1993-07-09 | 1993-08-18 | Inst Of Cancer The Research | Cell growth factor receptors |
US6001621A (en) * | 1993-11-23 | 1999-12-14 | Genetech, Inc. | Protein tyrosine kinases |
CA2175892C (en) * | 1993-11-23 | 2000-03-07 | Paul J. Godowski | Kinase receptor activation assay |
US5529925A (en) * | 1993-12-03 | 1996-06-25 | St. Jude Children's Research Hospital | Nucleic acid sequences and fusion proteins present in human t(2;5) lymphoma |
US5763198A (en) * | 1994-07-22 | 1998-06-09 | Sugen, Inc. | Screening assays for compounds |
US5759787A (en) * | 1996-08-26 | 1998-06-02 | Tularik Inc. | Kinase assay |
CA2288221A1 (en) * | 1997-04-28 | 1998-11-05 | Sugen, Inc. | Diagnosis and treatment of phosphatase 0r kinase-related disorders |
US6806266B1 (en) * | 1999-07-13 | 2004-10-19 | Kyowa Hakko Kogyo Co., Ltd. | Staurosporin derivatives |
-
2003
- 2003-03-07 DE DE60305634T patent/DE60305634T2/de not_active Expired - Fee Related
- 2003-03-07 PT PT03005186T patent/PT1454992E/pt unknown
- 2003-03-07 ES ES03005186T patent/ES2263862T3/es not_active Expired - Lifetime
- 2003-03-07 AT AT03005186T patent/ATE328112T1/de not_active IP Right Cessation
- 2003-03-07 DK DK03005186T patent/DK1454992T3/da active
- 2003-03-07 SI SI200330308T patent/SI1454992T1/sl unknown
- 2003-03-07 EP EP03005186A patent/EP1454992B1/en not_active Expired - Lifetime
-
2004
- 2004-03-04 WO PCT/EP2004/002185 patent/WO2004079326A2/en active Application Filing
- 2004-03-04 CN CNB2004800060187A patent/CN100345978C/zh not_active Expired - Fee Related
- 2004-03-04 CA CA002518094A patent/CA2518094A1/en not_active Abandoned
- 2004-03-04 JP JP2006504533A patent/JP2006519800A/ja active Pending
- 2004-03-04 US US10/547,842 patent/US20070031907A1/en not_active Abandoned
-
2005
- 2005-02-17 HK HK05101314A patent/HK1068154A1/xx not_active IP Right Cessation
- 2005-09-05 IL IL170669A patent/IL170669A0/en unknown
-
2006
- 2006-07-04 CY CY20061100923T patent/CY1106115T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2006519800A (ja) | 2006-08-31 |
CN1756850A (zh) | 2006-04-05 |
CY1106115T1 (el) | 2011-06-08 |
ATE328112T1 (de) | 2006-06-15 |
WO2004079326A2 (en) | 2004-09-16 |
US20070031907A1 (en) | 2007-02-08 |
DE60305634T2 (de) | 2006-09-21 |
WO2004079326A3 (en) | 2004-12-09 |
EP1454992B1 (en) | 2006-05-31 |
IL170669A0 (en) | 2011-08-01 |
SI1454992T1 (sl) | 2006-10-31 |
EP1454992A1 (en) | 2004-09-08 |
DK1454992T3 (da) | 2006-10-02 |
ES2263862T3 (es) | 2006-12-16 |
CN100345978C (zh) | 2007-10-31 |
PT1454992E (pt) | 2006-09-29 |
DE60305634D1 (de) | 2006-07-06 |
CA2518094A1 (en) | 2004-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1068154A1 (en) | Anaplastic lymphoma kinase assay, reagent and compositions thereof | |
WO2005111212A3 (en) | Biological bar code | |
AU2003278725A1 (en) | Polynucleotide predictor set for identifying protein tyrosine kinase modulators | |
ATE386815T1 (de) | Methoden und syteme zur überwachung intrazellulärer bindereaktionen | |
WO2004020458A3 (en) | Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents | |
WO2002047535A3 (en) | High throughput assay to detect inhibitors of the map kinase pathway | |
HK1080074A1 (zh) | 作為酪氨酸蛋白激酶抑制劑的4,6-二氨基取代-2-[氧基或氨氧基]-[1,3,5]三嗪 | |
EP1395275A4 (en) | BETA SECRETASE SUBSTRATES AND THEIR USE | |
WO2004050842A3 (en) | Atm kinase compositions and methods | |
WO2002053743A3 (en) | Mammalian tribbles signaling pathways and methods and reagents related thereto | |
EP2253722A3 (en) | Reagent and methods for detecting severe acute respiratory syndrome coronavirus | |
AU2002243912A1 (en) | Biosensor for detecting chemical agents | |
DE602006021548D1 (de) | Probenlyse und beschichtung einer reaktionsoberfläche | |
WO2003008635A8 (en) | η-SECRETASE IN VITRO SCREENING ASSAY | |
DK1224222T3 (da) | Chemokinreceptor | |
WO2004084708A3 (en) | Finding usable portion of sigmoid curve | |
WO2005100386A3 (en) | Canine cold-and menthol-sensitive receptor 1 | |
WO2005003388A3 (en) | Fluorescence assays for nucleic acid polymerase activity | |
HK1116517A1 (en) | Enzymatic measurement of imatinib mesylate | |
DE60226244D1 (de) | Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind | |
WO2004020980A3 (en) | Assays for the detection of biliverdin in birds and reptiles | |
WO2001071342A3 (en) | Identification of mast cell/basophil activation inhibitors | |
WO2005026378A3 (en) | Methods for gene function analysis | |
AU2003293303A1 (en) | Screening assay for identifying agents that modulate pak kinase or cd45 tyrosine phosphatase activity | |
NO20013748L (no) | Ny analyse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100307 |